About Rules-Based Medicine
Rules-Based Medicine is a company based in Austin (United States) founded in 2002 was acquired by Myriad Genetics in April 2011.. Rules-Based Medicine has raised $25 million across 1 funding round from investors including Myriad Genetics, The Stephens Group and Cross Creek. Rules-Based Medicine operates in a competitive market with competitors including Anabios, Clyde Biosciences, Metrion Biosciences, Quiver Bioscience and Zen-Bio, among others.
- Headquarter Austin, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$25 M (USD)
in 1 rounds
-
Latest Funding Round
$25 M (USD), Series A
Oct 15, 2007
-
Investors
Myriad Genetics
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Myriad Genetics
(Apr 27, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Rules-Based Medicine
Rules-Based Medicine has successfully raised a total of $25M through 1 strategic funding round. The most recent funding activity was a Series A round of $25 million completed in October 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $25.0M
-
First Round
First Round
(15 Oct 2007)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2007 | Amount | Series A - Rules-Based Medicine | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Rules-Based Medicine
Rules-Based Medicine has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Myriad Genetics, The Stephens Group and Cross Creek. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Sector-agnostic investments in late-stage startups are made by Cross Creek.
|
Founded Year | Domain | Location | |
|
Molecular diagnostics and personalized medicine for cancer are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rules-Based Medicine
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Rules-Based Medicine
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rules-Based Medicine Comparisons
Competitors of Rules-Based Medicine
Rules-Based Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Anabios, Clyde Biosciences, Metrion Biosciences, Quiver Bioscience and Zen-Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Ex-vivo human tissue studies are performed for preclinical drug discovery.
|
|
| domain | founded_year | HQ Location |
Cardiac safety testing is conducted using iPS-derived heart cells.
|
|
| domain | founded_year | HQ Location |
Ion channel screening and cardiac safety profiling services are provided.
|
|
| domain | founded_year | HQ Location |
Developer of transformational medicines for neurological disorders
|
|
| domain | founded_year | HQ Location |
Cell-based solutions are provided to accelerate therapy discovery and development.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Rules-Based Medicine
When was Rules-Based Medicine founded?
Rules-Based Medicine was founded in 2002 and raised its 1st funding round 5 years after it was founded.
Where is Rules-Based Medicine located?
Rules-Based Medicine is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Is Rules-Based Medicine a funded company?
Rules-Based Medicine is a funded company, having raised a total of $25M across 1 funding round to date. The company's 1st funding round was a Series A of $25M, raised on Oct 15, 2007.
What does Rules-Based Medicine do?
Rules-Based Medicine was founded in 2002 in Austin, United States, focusing on biotechnology diagnostics. Multiplexed biomarker assays are created using the Multi-Analyte Profiling platform for protein analysis. The company was acquired by Myriad Genetics in April 2011 for 80 million in cash and now functions as a subsidiary known as Myriad RBM, supporting biomarker research and development in the diagnostics sector.
Who are the top competitors of Rules-Based Medicine?
Rules-Based Medicine's top competitors include Metrion Biosciences, Quiver Bioscience and Anabios.
Who are Rules-Based Medicine's investors?
Rules-Based Medicine has 3 investors. Key investors include Myriad Genetics, The Stephens Group, and Cross Creek.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.